Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
January 24, 2024 at 05:33 am EST
Share
Aarti Drugs Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 6,059.4 million compared to INR 6,639.6 million a year ago. Revenue was INR 6,076.1 million compared to INR 6,649.7 million a year ago. Net income was INR 366.7 million compared to INR 366.8 million a year ago. Basic earnings per share from continuing operations was INR 3.99 compared to INR 3.96 a year ago. Diluted earnings per share from continuing operations was INR 3.99 compared to INR 3.96 a year ago.
For the nine months, sales was INR 19,085.9 million compared to INR 19,736.4 million a year ago. Revenue was INR 19,115.4 million compared to INR 19.75 million a year ago. Net income was INR 1,241.1 million compared to INR 1,102.2 million a year ago. Basic earnings per share from continuing operations was INR 13.47 compared to INR 11.9 a year ago. Diluted earnings per share from continuing operations was INR 13.47 compared to INR 11.9 a year ago.
Aarti Drugs Limited is an India-based company that is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates through pharmaceuticals segment. The Company's APIs products include ciprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole and ofloxacin, among others. Its specialty chemicals products include benzene sulphonyl chloride and methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include itraconazole, fluconazole, dabigatran, ticagrelor, sitagliptin and alpha lipoic acid. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SPA.
AARTI DRUGS LIMITED 
